ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0883

Serum Cholesterol Loading Capacity on Macrophages Is Dependent on Oxidized Low-density Lipoprotein and Regulated by Seropositivity and C-reactive Protein in Patients with Rheumatoid Arthritis

George A Karpouzas1, Bianca Papotti2, Sarah Ormseth3, Marcella Palumbo2, elizabeth Hernandez3, Maria Pia Adorni2, Francesca Zimetti2, Matthew Budoff4 and Nicoletta Ronda5, 1Division of Rheumatology, Harbor-UCLA Medical Center, Torrance, CA, 2University of Parma, Parma, Italy, 3The Lundquist Institute, Torrance, CA, 4Harbor-UCLA Medical Center and the Lundquist Institute, Torrance, CA, 5University of Parma, Parma

Meeting: ACR Convergence 2022

Keywords: Anti-CCP, Atherosclerosis, Biomarkers, rheumatoid arthritis, Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 13, 2022

Title: RA – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 9:00AM-10:30AM

Background/Purpose: Excessive cholesterol accumulation in macrophages underlies foam cell formation, initiation and progression of atherosclerosis. Low-density lipoprotein (LDL) oxidation and unregulated uptake by macrophages are critical in foam cell development. Cholesterol loading capacity (CLC) is the ability of serum to deliver cholesterol to cells and is related to foam cell formation. Rheumatoid arthritis (RA) serum increased cholesterol content in macrophages and promoted foam cell formation significantly more than control serum. We here explore factors in the serum of patients with RA and mechanisms through which they interact and influence CLC on macrophages.

Methods: In a cross-sectional observational cohort of 104 patients with RA, CLC was measured as intracellular cholesterol content in human THP-1-derived macrophages after incubation with patient serum. LDL oxidation was measured as oxidized phospholipids on apoB100-containing particles (oxPL-apoB100). Antibodies against oxidized LDL (anti-oxLDL), proprotein convertase subtilisin/Kexin type-9 (PCSK9) and high-sensitivity CRP were also quantified. All analyses adjusted for atherosclerotic cardiovascular disease (ASCVD) risk score, obesity, total LDL, statin use, age at diagnosis, and anti-oxLDL IgM.

Results: OxPL-apoB100, anti-oxLDL IgG and PCSK9 positively associated with CLC (all p< 0.020). OxPL-apoB100 directly influenced CLC only in dual rheumatoid factor and anti-citrullinated protein antibody positive patients (unstandardized b [95% bootstrap confidence interval]=2.08 [0.38-3.79]) and independently of CRP (Figure 1). An indirect effect of oxPL-apoB100 on CLC through anti-oxLDL IgG increased along with level of CRP (index of moderated mediation=0.55 [0.05-1.17]). CRP also moderated yet another indirect effect of oxPL-apoB100 on CLC through upregulation of PCSK9, but only among dual seropositive patients (conditional indirect effect=0.64 [0.13-1.30]).

Conclusion: Oxidized LDL can directly influence CLC in dual seropositive RA patients, regardless of CRP. This suggests that targeting LDL oxidation in addition to inflammation may enable a more comprehensive reduction of atherosclerotic risk in these patients. Two additional and independent pathways—via anti-oxLDL IgG and PCSK9—may further mediate the effects of oxPL-apoB100 on CLC depending on CRP level and seropositivity status. If externally validated, these findings may have clinical implications for cardiovascular risk prevention.

Supporting image 1

Figure 1 Direct and indirect effects of oxPL-apoB100 on CLC through parallel mediators PCSK9 and anti-oxLDL IgG depending on level of CRP and dual ACPA/RF seropositivity shown at (A) low CRP (1 SD below the mean) and dual seropositive, (B) high CRP (1 SD above the mean) and dual seropositive, (C) low CRP (1 SD below the mean) and not dual seropositive, and (D) high CRP (1 SD above the mean) and not dual seropositive. Dotted lines are the indirect effect of oxPL-apoB100 on CLC through PCSK9. Dashed lines are the indirect effect of oxPL-apoB100 on CLC through anti-oxLDL IgG. ASCVD risk score, statin use, LDL-C, anti-oxLDL IgM, obesity, and age at RA diagnosis were included as covariates but are not shown in the figure. Values are unstandardized regression coefficients.
oxPL-apoB100: oxidized phospholipids on apolipoprotein B100 particles, anti-oxLDL: antibodies against malondialdehyde LDL, PCSK9: proconvertase subtilisin/kexin type-9, CLC: cholesterol loading capacity, CRP: C-reactive protein, Seronegative: rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) negative, Single seropositive: RF or ACPA positive, Dual seropositive: both RF and ACPA positive, SD: standard deviation.*p<0.05, **p<0.01.


Disclosures: G. Karpouzas, Janssen, Sanofi-Genzyme-Regeneron, Pfizer Inc; B. Papotti, None; S. Ormseth, None; M. Palumbo, None; e. Hernandez, None; M. Adorni, None; F. Zimetti, None; M. Budoff, Pfizer; N. Ronda, None.

To cite this abstract in AMA style:

Karpouzas G, Papotti B, Ormseth S, Palumbo M, Hernandez e, Adorni M, Zimetti F, Budoff M, Ronda N. Serum Cholesterol Loading Capacity on Macrophages Is Dependent on Oxidized Low-density Lipoprotein and Regulated by Seropositivity and C-reactive Protein in Patients with Rheumatoid Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/serum-cholesterol-loading-capacity-on-macrophages-is-dependent-on-oxidized-low-density-lipoprotein-and-regulated-by-seropositivity-and-c-reactive-protein-in-patients-with-rheumatoid-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-cholesterol-loading-capacity-on-macrophages-is-dependent-on-oxidized-low-density-lipoprotein-and-regulated-by-seropositivity-and-c-reactive-protein-in-patients-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology